Manufacturers put their money behind productivity programmes

first_img Tags: Manufacturing sector Manufacturers put their money behind productivity programmes Sunday 28 June 2015 11:34 pm THE VAST majority of UK manufacturers are picking up the pace of investment, according to a new survey out today.The survey of 750 UK businesses with a turnover of £2m to £25m was carried out by Lombard Asset Finance for EEF, the manufacturers’ organisation.Seventy-one per cent of manufacturers surveyed said that they felt more confident than a year ago, and nearly all (95 per cent) of respondents said they were increasing investment to improve productivity.Seventy-two per cent said they were “investing to secure future growth or to replace aging equipment”, while 68 per cent of respondents said they were investing more in boosting export activity. Just one per cent of manufacturers polled said they were investing less than 12 months ago.Commenting on the results, EEF chief economist Lee Hopley said: “UK manufacturers’ on-going commitments to invest in technology, skills and innovation provide positive signals about the sector’s future growth and productivity prospects.” whatsapp Express KCS whatsapp More From Our Partners Brave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.orgInstitutional Investors Turn To Options to Bet Against AMCvaluewalk.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.orgRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comWhite House Again Downplays Fourth Possible Coronvirus Checkvaluewalk.comPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgFeds seized 18 devices from Rudy Giuliani and his employees in April raidnypost.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgKiller drone ‘hunted down a human target’ without being told tonypost.com Share Show Comments ▼last_img read more

‘A new instruction manual for life’: Single-cell sequencing is opening up new avenues for potential treatments

first_img STAT+: [email protected] Privacy Policy In the Lab‘A new instruction manual for life’: Single-cell sequencing is opening up new avenues for potential treatments Single-cell sequencing is the center point of his research. The advantage, he said, is that it allows you to measure 5,000 to 10,000 genes in each cell, and do it across many thousands of cells. The work’s been fruitful: This summer, for instance, Lein’s team announced that it used RNA sequencing on a single-cell scale to discover a new breed of neuron, dubbed the “rose hip cell” — so named because the axons, or nerve fibers, resemble a rose without its petals. The cells, which seem to exist only in humans, are thought to control how information flows from one part of the brain to others. The study analyzed just a handful of human brains, obtained postmortem, but included the analysis of thousands of cells in minute detail.“The field has changed so dramatically, and quickly,” Lein said. “Just a few years ago, studying a couple dozen transcriptomes would be a totally reasonable study. Now, we’re getting into the realm of millions of cells for a study.”The technique has also produced some fascinating insights in disease pathology. Take asthma, for instance: Nathan Jackson, a researcher at the Center for Genes, Environment, and Health at National Jewish Health in Denver, discovered the precise cells that misbehave during severe asthma attacks.He assayed the cells involved in type 2-high asthma, which affects about half of the people with the disease. It’s caused by elevated levels of signaling proteins, called type 2 cytokines, which prompt the cells lining the surface of the lungs to excrete a thick mucus. This ends up triggering some of the breathing difficulties associated with asthma.By analyzing the RNA with single-cell sequencing, Jackson and his colleagues found out the specific genes and proteins that prompt mucus production. Furthermore, they found 11 different states of these epithelial lung cells, as they changed in response to triggers in the environment,  morphing from innocuous into irritated cells that caused disease. “Imagine you were a biologist and didn’t have a microscope — and then I handed you one for the first time,” said Dr. Sam Behjati, a pediatric oncologist and single-cell researcher at the Wellcome Sanger Institute in Britain. “That’s how profound single-cell sequencing is. It lets us see what we haven’t seen before; it gives us a new instruction manual for life.” By Meghana Keshavan Nov. 21, 2018 Reprints Single-cell sequencing has tantalized scientists for several years. It was first described in 2009, and by 2013 earned the distinction of “Method of the Year” from Nature. Cost and technology hurdles initially kept its use at bay — but the field has begun to blossom as sequencing becomes more economical, and bioinformatic analysis becomes more reliable. advertisement Every plant, animal, and fungus is made up of an intricate amalgam of cells. Each cell type has its own unique function, life cycle, and reaction to its environment. These factors, in aggregate, inform how living things live, the way disease manifests, and why we die.Much of this synchronous web of biology is still a mystery: There’s so much we don’t understand about how individual cells work in tandem to keep a brain firing or a cancer metastasizing. But scientists, using a powerful technology called single-cell sequencing, have begun to peel apart the precise mechanisms of how individual cells operate. By quickly analyzing thousands — even millions — of cells in a single experiment, it’s now possible to visualize the specific cellular culprits for any given disease, how they might interact with their microscopic peers, and what molecules are involved in the process.advertisement Even if the price isn’t negligible, it’s well within reach for both research labs and larger pharmaceutical companies that are interested in this technology.“We want these instruments in all labs across the world, because we think this is how analysis should be done,” Hindson said.The Human Cell Atlas project — an international effort to create a detailed taxonomy of every cell type in the human body — has helped raise the profile of single-cell sequencing. The project is funded in part by the Chan Zuckerberg Initiative, the effort launched by Facebook CEO Mark Zuckerberg and his wife, Dr. Priscilla Chan, aimed at curing, preventing, or managing all disease “in our children’s lifetime.” Though the initiative is still in its nascency, scientists are already unveiling intriguing new insights into basic human biology thanks to the collaborations spawned by the Human Cell Atlas.Ed Lein, a researcher at the Allen Institute for Brain Science, is working on unraveling the cellular makeup of the human brain. The idea is to reverse-engineer the brain’s cortex, he said, to try and understand all of the types of cells within it — and then build up an understanding of how they’re all wired together.   Leave this field empty if you’re human: Single-cell sequencing, by contrast, can indicate which family has six children, and which has just one, and a dog, he said. It’s orders of magnitude more granular. “The value of single-cell sequencing, in this case, is the ability to look at how mutations work together to drive disease,” Silver said.Here’s how single-cell sequencing works: A cancer biopsy is teased apart, and each of the thousands of cells is locked into its own tiny test tube on a microfluidic chip, and then treated with a series of enzymes and chemicals to coax the necessary genetic material out.From there, the cells are tagged with their own “barcode” — a unique DNA- or RNA-based identifier that’s inserted into its genetic code. The cells are then probed for a predetermined set of variables: Scientists can check whether they carry a certain set of genes, or express specific molecules involved in disease pathogenesis. The data are aggregated, and through the magic of machine learning scientists can use that data to sort cells by their function and characteristics. Instead of averaging the genetic profile of the tissue sample, this analysis quantifies the prevalence of each different cell type — and can isolate the outliers. “If our customers analyze 10,000 cells from a sample, very often they’ll find a handful of these residual cells after a patient’s been treated that are still indicative of disease,” Silver said. “That’s the population that ends up relapsing and progressing.”Mission Bio is working with top institutions around the country — including MD Anderson, Mount Sinai, the National Cancer Institute, and the Stanford Cancer Center — to pore through patient tissue samples in search of residual cancer.Single-cell sequencing might ultimately help clinicians know whether a therapy is tailored to target the specific cell types that have gone rogue. The tool has particular implications for combination therapies, and could prove useful in clinical trial design, Silver said. Single-cell sequencing still isn’t cheap.10X Genomics, a biotech specializing in single-cell analysis, offers the microfluidics instruments necessary for this technology for about $75,000. It’ll cost about $1,280 — plus sequencing costs, which vary based on what’s being studied — for the necessary materials to study about 10,000 cells, said Ben Hindson, chief scientific officer of the company. Though the epithelial cells were obviously studied in a lab setting, they were cross-examined with the RNA expression from the nasal swabs of 698 children with type 2-high asthma — and the findings held up.Understanding the precise cellular processes that go awry in asthma could potentially lead to a new wave of asthma therapeutics, Jackson said. And it’s not just asthma: Identifying the pathways that lead to dysfunction in a specific cell type, such as the epithelial cells he analyzed, could allow scientists to develop drugs targeted exclusively to that particular population. “Once this technology became available, we realized there was so much low-hanging fruit,” Jackson said. “There are so many obvious questions we can answer with single-cell sequencing.” Celsius Therapeutics is using single-cell sequencing to drive its entire drug discovery process. Freshly launched this year with a $65 million series A round, the company is zeroing in on cancer and autoimmune disease.“We think these are two areas where whole genome sequencing has little impact,” said CEO Langaeur. Instead, his company is analyzing the RNA from the single cells involved in cancers and conditions like inflammatory bowel disease to find drug targets. The company’s agnostic on therapeutic modality — it’s open to both biologics and small molecule drugs — but thinks the single-cell approach will be very revealing.Indeed, single-cell sequencing could open the door for entirely different ways of approaching drug development. Newsletters Sign up for Daily Recap A roundup of STAT’s top stories of the day. About the Author Reprints Academics and drug makers alike are increasingly looking for ways to exploit this powerful new technology. Interrogating individual cells on their identity and purpose is turning up stunning new insights on basic biology — and providing rich fodder for drug discovery. Try to picture a mass of cancer cells. Tumors are bedeviling in their complexity: They can comprise both of mutant and healthy cell types, and operate in their own ever-expanding microenvironment.Although it’s possible to identify tissue as cancerous by examining it under a microscope, or even by sequencing a biopsy, it’s difficult to isolate which specific cells are benign — and which might evade therapy, mutate, and lead to further metastasis. “It’s Darwinian evolution, literally,” said Charlie Silver, CEO of Mission Bio, a biotech spinout of the University of California, San Francisco, that provides single-cell sequencing services to cancer hospitals, researchers, and pharmaceutical companies. “Cancer is not one mutation — it’s many mutations on different cells that work together to drive disease.”Most clinical sequencing efforts work by the law of averages: Genetic analysis is conducted on entire populations of cells, so subtle differences between them aren’t clear, making it hard to to isolate the most malignant. And those subtle differences are what drive each individual cancer’s pathology.Standard genetic analysis techniques give us some insights, but they can be murky — not unlike population surveys, as Christoph Lengauer, CEO of Celsius Therapeutics, a Cambridge, Mass., biotech, points out.“Population surveys tell us the average American family has 1.2 children. That’s useless. That’s not helpful. Not a single family has 1.2 children,” said Lengauer, whose company is using single-cell sequencing to find new drug targets. Exclusive analysis of biopharma, health policy, and the life sciences. Human cell showing the nucleus in red and the tubulin component of the cytoskeleton in green. The blue staining is a single cytoplasmic protein. Matthew Daniels/Wellcomecenter_img Offering free DNA sequencing, Nebula Genomics opens for business. But there’s an itsy-bitsy catch NewslettersSign up for The Readout Your daily guide to what’s happening in biotech. Trending Now: Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson Leave this field empty if you’re human: Behjati of Wellcome Sanger made a startling observation in his own cancer research. After sequencing reams of kidney cancer cells, he has — as expected— found a litany of unique mutations. But he noticed that while the kidney cancer cells may be genetically disparate from one another, they generally behaved and looked alike. The cancer cells’ instruction manuals may have been worded differently, but the end result was more or less the same, he said. “On the DNA level, kidney cancers are very heterogeneous — but if you looked at the cancer on a cellular level, all the cancer cells are the same,” he said. “I think we’re getting distracted by the heterogeneity.”So Behjati has a slightly unorthodox viewpoint on the future of drug development — using insight gleaned from his work with single-cell sequencing.His hypothesis, when it comes to drug development, would be to focus more on the cell type and less on the intricacies of DNA and RNA that drive the mutations. “Let’s look for drugs that change the cell type, and disrupt the cancer that way,” he said. “At the end of the day, what kills you is not the mutation, but the cancer cell.” Related: Please enter a valid email address. Cartoons offer a peek into cancer immunotherapy — and scientists’ minds Privacy Policy Please enter a valid email address. @megkesh Related: Biotech Correspondent Meghana covers biotech and contributes to The Readout newsletter. Meghana Keshavan Tags geneticsresearchlast_img read more

Valued for their tech, Silicon Valley digital health companies rely heavily on armies of faraway coaches

first_img What’s included? GET STARTED Hyacinth Empinado/STAT Valued for their tech, Silicon Valley digital health companies rely heavily on armies of faraway coaches SAN FRANCISCO — Talk to investors about why they like Omada Health, and they point you first to its technology. The startup, they rave, deploys sleek devices to monitor patients with chronic medical conditions; it collects millions of data points on their behavior; and it uses machine learning and other artificial intelligence techniques to automate health reminders and to flag individuals who need more intervention.It’s a robust operation. It would also fall apart without the likes of DJ Moberly, a “health coach” who spends much of her day exchanging messages with Omada’s diabetes patients from her home in the Houston area — helping them set and stick to goals, encourage them to eat healthy, and offering them tips about controlling their blood sugar levels. Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. First 30 days free. GET STARTED What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Health Tech Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. By Rebecca Robbins Nov. 13, 2019 Reprints Log In | Learn More Tags diabeteshealth techlast_img read more

Digital event: Combating Covid-19 — Part 3

first_imgBiotechDigital event: Combating Covid-19 — Part 3 Matthew Herper Senior Writer, Medicine, Editorial Director of Events Matthew covers medical innovation — both its promise and its perils. Editor’s note: The archived video recording is embedded below.The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed.Join STAT for a three-part digital event series. Part 3, “Vaccines — can they come soon enough?” is today. The first part on April 8 discussed antibody drugs that target the coronavirus, and the second part on April 29 discussed fighting Covid-19 on multiple fronts.advertisement A version of this recording with closed captioning can be found on STAT’s YouTube page here.  @matthewherper [email protected] Tags Coronavirus About the Author Reprints Part 3: Vaccines — can they come soon enough? May 6 at 1 p.m. ESTSponsor Introduction: Clem Lewin, Ph.D., associate vice president of R&D strategy for vaccines, SanofiTal Zaks, chief medical officer, ModernaMatthew Herper, senior writer, medicine, and editorial director of events, STAT Combating Covid-19: Part 3 – Vaccines — can they come soon enough?Volume 90%Press shift question mark to access a list of keyboard shortcutsKeyboard ShortcutsEnabledDisabledPlay/PauseSPACEIncrease Volume↑Decrease Volume↓Seek Forward→Seek Backward←Captions On/OffcFullscreen/Exit FullscreenfMute/UnmutemSeek %0-9 facebook twitter Email Linkhttps://www.statnews.com/2020/05/06/digital-event-combating-covid-19-part-3/?jwsource=clCopied EmbedCopiedLive00:001:03:051:03:05  By Matthew Herper May 6, 2020 Reprintslast_img read more

Beachgoers join in search for engagement ring lost on Marco Island

first_imgWATCH: Plane caught on video getting very close to Marco Island beach May 19, 2021 AdvertisementThankfully, after two and half hours of searching the ring was found.“I mean I was crying, she was crying. Best feeling ever,” Nathan Oldani said. “It would have been really hard to go on the rest of this trip without that ring, we’d probably be out at that spot every day trying to look for it still.”The couple is set to get married in October.  Advertisement Missing Marco Island man found safe May 26, 2021 AdvertisementRecommended ArticlesBrie Larson Reportedly Replacing Robert Downey Jr. As The Face Of The MCURead more81 commentsGal Gadot Reportedly Being Recast As Wonder Woman For The FlashRead more29 comments RELATEDTOPICS Marco Island Police investigate string of car thefts May 11, 2021center_img AdvertisementTags: engagementlost ringmarco island MARCO ISLAND, Fla. — A memorable moment turned nightmare for a recently engaged couple visiting Marco Island. The pair said that they nearly lost their engagement ring while taking sunset pictures on the beach.“It was just traumatic, crying trying to find it. It was just crazy,” Ashley Sink said. “Oh my gosh, I just lost the lost important thing at our life’s stage right now.”Beachgoers and police officers chipped in to help the couple search for the ring that was lost in the sand.  AdvertisementDC Young Fly knocks out heckler (video) – Rolling OutRead more6 comments’Mortal Kombat’ Exceeded Expectations Says WarnerMedia ExecutiveRead more2 commentsDo You Remember Bob’s Big Boy?Read more1 commentsKISS Front Man Paul Stanley Reveals This Is The End Of KISS As A Touring Band, For RealRead more1 comments Tour guides work to reduce trash on Dickman’s Point May 19, 2021 Advertisementlast_img read more

43 homes repossessed by Laois County Council

first_img Facebook Twitter Community Fianna Fail TD Sean Fleming said: “Per capita, the repossessions in Laois by the Local Authority is at least 3 times the national average. This needs to be explained.“Everybody accepts that mortgages have to be sustainable and the Council as a mortgage provider/lender must take action when mortgages are not being repaid.“Over the years people in Laois have been in contact with me about legal proceedings by financial institutions against them in respect of their mortgage arrears.“When investigating these matters it became clear to me that Laois County Council was also very active in seeking repossessions.“I asked the Department and Laois County Council in the past why the Laois figures are so high.“There should be a consistent approach across all Local Authorities.“There has been no clear answer as to why the repossessions are so high in Laois relative to other counties.“The public needs to know is there a different approach being taken by Laois County Council compared with other Local Authorities.“I raised the issue of Local Authority Mortgage Arrears at the Public Accounts Committee in April and received the attach document from the Department in recent days.“Page 9 gives the National figures for Local Authority Mortgage Arrears Repossessions 2010 to Q3 2017.”SEE ALSO – 14-man Laois defeat Antrim to throw Joe McDonagh Cup hopes a lifeline 43 homes repossessed by Laois County Council Rugby WhatsApp Laois County Council Laois County Council has repossessed 43 houses as a result of mortgage arrears between 2010 and September 2017.16 of these repossessions were forced on foot of a Court order and the other 27 repossessions were by voluntarily surrender or abandonment.Repossession on foot of a Court order by Laois County Council is the second highest of all counties in the country (excluding Cork, Dublin and Galway). The figures in Kildare are higher.When it comes to repossessions which are achieved on a voluntarily-surrender basis Laois is again near top of the list in the country.Overall, outside of the main cities, Laois County Council ranks 4th highest for Local Authority repossessions. By Alan Hartnett – 21st May 2018 TAGSHouse repossessionsLaois County Council Ten Laois based players named on Leinster rugby U-18 girls squad Twittercenter_img Pinterest Home News 43 homes repossessed by Laois County Council News Five Laois monuments to receive almost €200,000 in government funding Pinterest WhatsApp Facebook RELATED ARTICLESMORE FROM AUTHOR Charlie Flanagan on Electric Picnic: ‘I’d ask organisers to consult with community leaders’ Previous articleRenowned singer to speak on mental health in PortarlingtonNext articleMW Hire set to show off class new pink digger in aid of great cause at Open Day this week Alan HartnettStradbally native Alan Hartnett is a graduate of Knockbeg College who has worked in the local and national media since 2008. Alan has a BA in Economics, Politics and Law and an MA in Journalism from DCU. His happiest moment was when Jody Dillon scored THAT goal in the Laois senior football final in 2016. Community last_img read more

Coast Capital, Qtrade to expand partnership

Share this article and your comments with peers on social media There’s $149 million in B.C.’s lost and found The expanded agreement would also further Coast Capital’s relationship with Montreal-based Desjardins Group, which purchased 40% of Qtrade’s shares early this month. In early April, Coast Capital made an agreement with the Quebec-based credit union to share expertise in products and services. Executives with Qtrade and Coast Capital expect an announcement on the final details of the partnership will be made before the end of the year. With 504,000 members Coast Capital is the largest credit union in Canada by membership. The credit union has a total of $14.6 billion in assets under administration and operates 50 branches in Vancouver, Fraser Valley and Vancouver Island. Qtrade provides extensive brokerage and wealth management platforms, services and solutions to Canadian retail clients and the customers of financial institutions. Surrey, B.C.-based Coast Capital Savings Credit Union and Vancouver-based Qtrade Financial Group have signed a letter of intent to expand their current wealth management relationship, the companies announced on Friday. The companies will now begin a period of negotiation, which, if successful, will allow Coast Capital to access Qtrade’s dealer and back office support for wealth management services. Merger of B.C. financial services, real estate regulators nears completion Ontario regulator to provide $500M credit facility to PACE Credit Union Related news Keywords Credit unionsCompanies Coast Capital Savings Credit Union, Desjardins Group, Qtrade Financial Group IE Staff Facebook LinkedIn Twitter read more

IA launches Prestige Series seg funds for affluent investors

first_img CI GAM and Empire Life launch seg fund suite Quebec City-based Industrial Alliance Insurance and Financial Services Inc. (IA) announced the launch of the Prestige Series of segregated funds on Monday for clients whose consolidated assets with the company have a market value of $300,000 or higher. IA also announced that it is offering a significant reduction in the management expense ratio (MER) for these seg funds, which now vary between 0.10% and 0.55%, depending on the fund. IE Staff The two new Prestige Series offer investors a wide range of segregated funds that meet all risk profiles. The new series are Classic Series 75/75 Prestige (75 funds) and Series 75/100 Prestige (70 funds). The reduced MER is applied to all funds in the two new series. Qualification for this reduction in MER is determined on a weekly basis and is applied automatically without any action required by the advisor or the client. When a client qualifies, the reduction is applied to assets held in Classic Series 75/75 or Series 75/100. The company automatically transfers the fund units to the equivalent Prestige Series funds. “Adding the Prestige Series reaffirms our commitment to offering customized solutions to our clients, particularly to clients who have significant assets with IA. These rigorous investors are seeking growth and prosperity and our solution will help them reach these goals”, says Manon Gauthier, vice president, individual savings and retirement, with IA in a statement. Keywords Segregated fundsCompanies Industrial Alliance Insurance and Financial Services Facebook LinkedIn Twitter Canada Life to launch new shelf of mutual funds Empire Life launches three new seg funds Related news Share this article and your comments with peers on social media last_img read more

Valentine’s Day lockdown heartbreaking for Victorian small businesses

first_imgValentine’s Day lockdown heartbreaking for Victorian small businesses The Australian Small Business and Family Enterprise OmbudsmanThe Australian Small Business and Family Enterprise Ombudsman Kate Carnell says the Victorian Government needs to urgently compensate small businesses forced to close their doors on one of the busiest holidays of the year.“Small businesses such as florists and restaurants currently have their storage rooms packed with supplies, ahead of what they thought would be one of their busiest trading days of the year,” Ms Carnell says.“Unfortunately, this snap lockdown means thousands of Victorian small businesses need to shut up shop for five days without any notice.“It is for this reason the Victorian Government needs to immediately announce a compensation package for affected small businesses who have lost stock such as flowers and food.“The compensation should also cover all other costs associated with running a business including staff wages and rent.“It is impossible for small businesses to plan for sudden lockdowns and the timing of this one – coinciding with Valentine’s Day and Lunar New Year celebrations – could not be worse.“Victorian restaurant owners are understandably frustrated, given this lockdown announcement came just hours after their additional supplies were delivered. Many were fully-booked all weekend.“These small businesses are set to lose thousands of dollars worth of stock through no fault of their own. Given the nightmarish 12 months these cash-strapped small businesses have already been through, there’s a real risk this lockdown could break them. “It’s absolutely critical these small businesses have the support and certainty they need from the Victorian Government to get through this.” /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:Australia, Australian, business, compensation, Family, food, Government, lockdown, Lunar, Ombudsman, rent, restaurant, running, Small Business, Victorialast_img read more

Chancellor’s Corner: Diversity and Inclusion Summit

first_imgChancellor Philip P. DiStefanoNext week marks the 23rd annual Diversity and Inclusion Summit, and I urge all students, faculty and staff to take a role in advancing the campus’s commitment to being a diverse and inclusive community at the summit Nov. 7–8.Please join Boulder City Manager Jane Brautigam, CU Student Government President of Student Affairs Betsy Sabala and myself as we open the summit at 9 a.m. Tuesday, Nov. 7, in the Glenn Miller Ballroom.Achieving a diverse and inclusive community is vital to our campus imperatives of creating tomorrow’s leaders, being the top university for innovation and impacting humanity.It is our moral imperative, and it is critical to the success of our campus, to honor diversity and inclusivity in all forms: ethnicity, race, gender, sexual orientation, disabilities, religious preferences, socio-economic status, age, intellectual, political or geographic diversity.Everyone in our community should feel engaged, valued and supported. We know campus social climate is foundational to the success of our students. We want everyone to thrive and reach their full potential at CU Boulder.Our goal for creating an inclusive campus is supported by the Colorado Creed, which our students gave to us 14 years ago. The creed calls for respecting the rights of others, celebrating our differences and contributing to the greater good of the community.It reminds us that the dialogue we will have at the Diversity and Inclusion Summit should not be limited to an annual or bi-annual event but be a part of our daily conversation. Given the events our country has experienced in recent weeks and months, the Colorado Creed is more important than ever.  Sharing and learning from people from diverse backgrounds and perspectives makes us all richer, smarter and better citizens of the world. Constantly seeking a diverse perspective should be woven into our fiber as a higher-education institution.While we all share a commonality as campus community members, we are each a product of our individual cultures and personal backgrounds.Sharing our personal journeys and cultural backgrounds makes us a better university. By working together, we can continue to elevate CU to new heights of shared humanity.While we each have our personal histories, we need to identify our barriers as a campus that keep us from connecting. What is holding us back from being the inclusive and accepting place we want to be? We have questions, but we don’t have all the answers. Taking on those questions is the value of this annual summit.It takes the collective wisdom and experiences of all of us, as individuals with personal narratives, to work together to find solutions.Please join me at the Diversity and Inclusion Summit Nov. 7–8.Philip P. DiStefano,Chancellor Published: Nov. 1, 2017 As a first-generation college student growing up in the Rust Belt of Ohio, I know both the challenges and the opportunities that other first-generation college students face. By being a part of an inclusive community that values diversity and respect for all students, the challenges diminish and the opportunities increase. Growing up in a diverse community that welcomed and respected all allowed me to be successful. I carried this experience with me as I navigated through undergraduate and graduate education to pursue a career in education that led to being the chancellor of our great university. Categories:Leadership CornerCampus Community Share Share via TwitterShare via FacebookShare via LinkedInShare via E-maillast_img read more